HER2 positive gastric cancer: Who benefits from HER2 targeted therapy?

  • K. Kolbe
  • , I. Haffner
  • , K. Schierle
  • , D. Maier
  • , B. Geier
  • , B. Luber
  • , A. Kretzschmar
  • , Fischer L. von Weikersthal
  • , M. Ahlborn
  • , J. Riera
  • , B. Rau
  • , G. Siegler
  • , S. Fuxius
  • , T. Decker
  • , C. Wittekind
  • , F. Lordick

Research output: Contribution to journalOriginal Articlepeer-review

Original languageUndefined/Unknown
JournalOncology Research and Treatment
Publication statusPublished - 2020

Cite this